KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Operating Income (2016 - 2025)

Exact Sciences (EXAS) has disclosed Operating Income for 16 consecutive years, with -$82.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Income rose 90.58% to -$82.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$206.3 million, a 80.33% increase, with the full-year FY2025 number at -$206.3 million, up 80.33% from a year prior.
  • Operating Income was -$82.6 million for Q4 2025 at Exact Sciences, down from -$25.5 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $6.8 million in Q3 2023 to a low of -$876.4 million in Q4 2024.
  • A 5-year average of -$146.0 million and a median of -$101.4 million in 2024 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: skyrocketed 104.96% in 2023, then plummeted 1191.77% in 2024.
  • Exact Sciences' Operating Income stood at -$221.4 million in 2021, then skyrocketed by 46.32% to -$118.9 million in 2022, then soared by 42.93% to -$67.8 million in 2023, then tumbled by 1191.77% to -$876.4 million in 2024, then soared by 90.58% to -$82.6 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Operating Income are -$82.6 million (Q4 2025), -$25.5 million (Q3 2025), and -$2.1 million (Q2 2025).